Dr. Juan Gallo
Staff researcher, Nanomedicine group, Dept of Life Sciences, International Iberian Nanotechnology Laboratory (Braga, Portugal)
Our group (Advanced magnetic Theranostic Nanostructures, AmTheNa) works on the application of nanotechnology into the biomedical field, both in the diagnostic process and the therapeutic part. We currently divide our efforts into two different but complementary areas. On one hand we carry out fundamental research in the area of Magnetic Resonance Imaging (MRI) contrast agents, Magnetic Hyperthermia (MH) effectors, and controlled drug delivery, mainly from a Chemistry point of view. This is the field in which we would have more interaction with EURELAX. For example, in the last years we have been quite active in the study of the interactions between T1 and T2 contrast agents through different strategies, always from an experimental point of view (Influence of the separation procedure on the properties of magnetic nanoparticles: Gaining in vitro stability and T1–T2 magnetic resonance imaging performance, Guldris N, et al, J. Colloid Inter. Sci., 2016, 472, 229; Tuning the relaxation rates of dual-mode T1/T2 nanoparticle contrast agents: a study into the ideal system, Keasberry NA, et al Nanoscale, 2015, 16119; Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobes, Gallo J*, et al, Nanoscale, 2017, 9, 11318). On the other hand, we focus on applied problems in the biomedical field trying to develop MRI and MH solutions in fields like Oncology or Neuroscience.